Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories
Effect of Sacubitril-Valsartan on Cardiac Structure and Function (clinicaltrials.gov) - Oct 10, 2026 - P3 | N=45 | Recruiting | Sponsor: Mayo Clinic | Trial completion date: Dec 2026 ➔ Aug 2028 | Trial primary completion date: Dec 2026 ➔ Aug 2028 
Trial completion date • Trial primary completion date • Cardiovascular • CST3
http://clinicaltrials.gov/ct2/show/NCT06693674
 
Oct 10, 2026
 
Prev Next